Pfizer Limited (BOM:500680)
India · Delayed Price · Currency is INR 4,817.10
-74.50 (-1.52%)
At close: Apr 21, 2026
Pfizer Market Cap
Pfizer has a market cap or net worth of 220.34 billion as of April 22, 2026. Its market cap has increased by 21.23% in one year.
Market Cap
220.34B
Enterprise Value
194.20B
Revenue
24.82B
Ranking
n/a
PE Ratio
25.82
Stock Price
4,817.10
Market Cap Chart
Since March 12, 1999, Pfizer's market cap has increased from 33.02B to 220.34B, an increase of 567.39%. That is a compound annual growth rate of 7.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 21, 2026 | 220.34B | -3.43% |
| Dec 31, 2025 | 228.18B | -5.56% |
| Dec 31, 2024 | 241.62B | 23.72% |
| Dec 29, 2023 | 195.29B | -3.67% |
| Dec 30, 2022 | 202.74B | -12.34% |
| Dec 31, 2021 | 231.27B | -1.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Abbott India | 548.17B |
| GlaxoSmithKline Pharmaceuticals | 415.35B |
| J. B. Chemicals & Pharmaceuticals | 320.69B |
| AstraZeneca Pharma India | 212.72B |
| Granules India | 162.16B |
| Rubicon Research | 148.09B |
| Jubilant Pharmova | 144.39B |
| Caplin Point Laboratories | 134.73B |